Genmab Announces Net Sales of DARZALEX® (daratumumab) for 2022
24/1 12:28
Company Announcement Net sales of DARZALEX ® in 2022 totaled USD 7, 977 million Genmab receives royalties on worldwide net sales from Janssen Biotech, Inc . (Janssen) COPENHAGEN, Denmark; January 24, 2023 – Genmab A/S (Nasdaq: GMAB) announced today that worldwide net trade sales of DARZALEX ®...